From 1 November 2020, the Australian Government is introducing two new items on the MBS for the treatment of cutaneous T-cell lymphoma (CTCL) with extracorporeal photopheresis (ECP).

Item 14247: ECP for the first six months of treatment for cutaneous T-cell lymphoma administered under the supervision of a specialist or consultant physician in the speciality of haematology, with a schedule fee of $1,908.35.

Item 14249: ECP for after the first six months of treatment for cutaneous T-cell lymphoma administered under the supervision of a specialist or consultant physician in the speciality of haematology, with a schedule fee of $1,908.35.

Factsheet

Last updated, 26 October 2020.
PDF version Factsheet ECP Treatment of CTCL (PDF 183 KB)
Word version Factsheet ECP Treatment of CTCL (DOCX 85 KB)